Software Slump Sees Another Leveraged Loan Deal Put on Hold

German healthcare software company Dedalus paused a €1.3 billion ($1.5 billion) leveraged loan deal amid rising investor unease around the existential challenge many firms in the sector face from developments in artificial intelligence.

The transaction, to reprice an existing term loan, has been postponed, according to a person familiar with the deal, who spoke on condition of anonymity. Commitments were due on Thursday.